186 related articles for article (PubMed ID: 1858829)
21. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine.
Stall GM; Harris S; Sokoll LJ; Dawson-Hughes B
Ann Intern Med; 1990 Aug; 113(4):265-9. PubMed ID: 2375563
[TBL] [Abstract][Full Text] [Related]
22. Effects of levothyroxine suppressive therapy on bone mineral density in premenopausal women.
Larijani B; Gharibdoost F; Pajouhi M; Sadjadi A; Aghakhani S; Eshraghian R; Akrami SM; Maalouf G
J Clin Pharm Ther; 2004 Feb; 29(1):1-5. PubMed ID: 14748891
[TBL] [Abstract][Full Text] [Related]
23. Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.
Garton M; Reid I; Loveridge N; Robins S; Murchison L; Beckett G; Reid D
Clin Endocrinol (Oxf); 1994 Dec; 41(6):747-55. PubMed ID: 7889610
[TBL] [Abstract][Full Text] [Related]
24. High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma.
Mazziotti G; Formenti AM; Frara S; Olivetti R; Banfi G; Memo M; Maroldi R; Giubbini R; Giustina A
J Clin Endocrinol Metab; 2018 Mar; 103(3):956-964. PubMed ID: 29121201
[TBL] [Abstract][Full Text] [Related]
25. Thyrotoxic bone disease in women: a potentially reversible disorder.
Diamond T; Vine J; Smart R; Butler P
Ann Intern Med; 1994 Jan; 120(1):8-11. PubMed ID: 8250460
[TBL] [Abstract][Full Text] [Related]
26. The effect of long-term thyroxine on bone mineral density and serum cholesterol.
Fowler PB; McIvor J; Sykes L; Macrae KD
J R Coll Physicians Lond; 1996; 30(6):527-32. PubMed ID: 8961207
[TBL] [Abstract][Full Text] [Related]
27. Does Graves' disease during puberty influence adult bone mineral density?
Radetti G; Bona G; Corrias A; Cappa M; DeSanctis V; Lauriola S; Paganini C; Rigon F
Horm Res; 2002; 58(4):176-9. PubMed ID: 12324715
[TBL] [Abstract][Full Text] [Related]
28. Bone mineral density in patients receiving suppressive doses of thyroxine for thyroid carcinoma.
Florkowski CM; Brownlie BE; Elliot JR; Ayling EM; Turner JG
N Z Med J; 1993 Oct; 106(966):443-4. PubMed ID: 8233173
[TBL] [Abstract][Full Text] [Related]
29. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral density in patients with endogenous subclinical hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
Földes J; Tarján G; Szathmari M; Varga F; Krasznai I; Horvath C
Clin Endocrinol (Oxf); 1993 Nov; 39(5):521-7. PubMed ID: 8252739
[TBL] [Abstract][Full Text] [Related]
31. Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism.
Affinito P; Sorrentino C; Farace MJ; di Carlo C; Moccia G; Canciello P; Palomba S; Nappi C
Acta Obstet Gynecol Scand; 1996 Oct; 75(9):843-8. PubMed ID: 8931510
[TBL] [Abstract][Full Text] [Related]
32. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
[TBL] [Abstract][Full Text] [Related]
33. Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease.
Jódar E; Martínez-Díaz-Guerra G; Azriel S; Hawkins F
Calcif Tissue Int; 2001 Aug; 69(2):84-7. PubMed ID: 11683428
[TBL] [Abstract][Full Text] [Related]
34. Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.
Camozzi V; Lumachi F; Mantero F; Piccolo M; Luisetto G
Osteoporos Int; 2003 Jul; 14(7):602-8. PubMed ID: 12730752
[TBL] [Abstract][Full Text] [Related]
35. Relations between calcidiol serum levels and bone mineral density in postmenopausal women with low bone density.
Martínez ME; del Campo MT; Sánchez-Cabezudo MJ; Garcia JA; Sánchez Calvín MT; Torrijos A; Coya J; Munuera L
Calcif Tissue Int; 1994 Oct; 55(4):253-6. PubMed ID: 7820775
[TBL] [Abstract][Full Text] [Related]
36. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen.
Schneider DL; Barrett-Connor EL; Morton DJ
JAMA; 1994 Apr; 271(16):1245-9. PubMed ID: 7848399
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone(1-84) treatment of postmenopausal women with low bone mass receiving hormone replacement therapy.
Fogelman I; Fordham JN; Fraser WD; Spector TD; Christiansen C; Morris SA; Fox J
Calcif Tissue Int; 2008 Aug; 83(2):85-92. PubMed ID: 18626566
[TBL] [Abstract][Full Text] [Related]
38. The effect of suppressive thyroxine therapy in nodular goiter in postmenopausal women and 2 year's bone mineral density change.
Chen CY; Chen ST; Huang BY; Hwang JS; Lin JD; Liu FH
Endocr J; 2018 Nov; 65(11):1101-1109. PubMed ID: 30158361
[TBL] [Abstract][Full Text] [Related]
39. Bone mineral density in premenopausal women receiving long-term physiological doses of levothyroxine.
Kung AW; Pun KK
JAMA; 1991 May 22-29; 265(20):2688-91. PubMed ID: 2023349
[TBL] [Abstract][Full Text] [Related]
40. The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma.
Moon JH; Jung KY; Kim KM; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
Bone; 2016 Feb; 83():104-110. PubMed ID: 26518742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
